Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Learn how to choose between price and TRI indices for benchmarking your investments. This quick intro explains key differences and why the right choice matters for performance comparison.
27,883 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Anthropic’s latest coding assistant is reshaping how enterprises buy software, potentially ending seat-based licenses...
Ohio suspends new data-center tax breaks after costs surge to $1.5B, triggering a review and a heated debate over AI ...
German carmakers posted steep Q2 declines in China, with losses up to 41%. The drop highlights ongoing headwinds from...
As the Iran conflict enters its fourth month, public support remains tepid and markets react differently. This story ...
As HIVE Digital Technologies prepares to report Q4 results, the stock has surged more than 100% in May. Traders are w...
Wendy’s faces traffic losses even as it pursues a turnaround with Project Fresh, while McDonald’s leans on loyalty an...
NVIDIA lands a major China AI chip deal, signaling a powerful push into the region’s AI buildout. Yet a 25% tariff th...
A June breach hit Humanity Protocol’s H token on Ethereum and BNB Smart Chain, revealing key-management vulnerabiliti...
Meta Platforms is dialing up AI infrastructure spending, guiding 2026 capex to $125-145 billion after a strong Q1. Th...
IGV climbed roughly 5% over the past week, defying a broader tech pullback. Yet traders remain split on whether the A...
Executives gathered at the Fortune CEO Initiative dinner to debate debt risks, global diplomacy, and the role of busi...